Učitavanje...
Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public Policy
The demonstration of bioequivalence (BE) is an essential requirement for ensuring that patients receive a product that performs as indicated by the label. The BE standard for a particular product is set by its innovator, and this standard must subsequently be matched by generic drug products. The Bi...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228645/ https://ncbi.nlm.nih.gov/pubmed/21775984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2011.109 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|